Unichem Laborataries Ltd - 506690

Name of Company	Unichem Laborataries Ltd
BSE Code	506690
NSE Code	UNICHEMLAB
ICICI Code
Established
My Take	Like
Headquarters	Mumbai
Promoters	Established by Amrut Mody – now Prakash Mody
Story	Has 6 drug manufacturing facilities in the country. R&D facility in Mumbai. Niche Generics is a wholly owned UK subsidiary – currently loss making and this is expected to turn a profit in FY12.
Sector	Pharma
Sub-sector	Formulations. Also API's
Website	http://www.unichemlabs.com/
Positives	High NPM's 16 to 19% except in FY08 when it was 13%. Low debt (interest cost is 51 lakhs in FY10, 22 Cr loan for a 134 Cr FY10 profit) – it has been historically debt free as well. Can expect to make around 33 Cr profit every quarter-very dependable company. Regular Dividend payer- yield expected is > 1.3%. 48% Promoter holding. US business is also picking up (CRAMS) – this can lead to heavy business growth.
Negatives	No reserves for FY10- earlier had good reserves. Revenues have grown from 455 Cr to 690 Cr from FY06 to FY10. At the same time profits grew from 82 Cr to 134Cr.
Peers
News
Price @ blogged	226 (21-Oct-10)
Cost of company	2033 Cr for a FY NP of 134 Cr makes it 15 times.